PHARMACEUTICAL CARE IN GESTATIONAL HYPERTENSION: PATHWAYS TO A CLINICAL, ETHICAL, AND HUMANIZED APPROACH

Abstract

Introduction: Hypertension during pregnancy remains one of the leading causes of maternal and perinatal morbidity and mortality, requiring continuous and qualified clinical care. Severe forms, such as preeclampsia and eclampsia, pose significant risks to both mother and fetus, particularly in socially vulnerable contexts with limited prenatal access. Objective: To analyze the pharmacist’s role in managing gestational hypertension, emphasizing their clinical and educational contributions to comprehensive and humanized care. Methodology: An integrative literature review with a qualitative approach was conducted using national and international databases (BVS, LILACS, SciELO, PubMed, and Google Scholar), covering publications from 2020 to 2025. Results and Discussion: The inclusion of pharmacists in multidisciplinary teams significantly improves rational medication use, prevents complications, enhances therapeutic adherence, and promotes maternal autonomy. However, the findings reveal gaps in clinical integration and limited recognition of pharmacists as essential members of maternal healthcare. Conclusion: The effective participation of pharmacists in the care of women with gestational hypertension represents a key advancement in maternal and child health, highlighting the importance of strengthening public policies that expand their clinical and educational roles.